Swot Analysis of "GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS" written by Michael Yaziji, Anna Lindblom includes – strengths weakness that are internal strategic factors of the organization, and opportunities and threats that Imd449 Imd448 facing as an external strategic factors. Some of the topics covered in GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS case study are - Strategic Management Strategies, Intellectual property and Leadership & Managing People.
Some of the macro environment factors that can be used to understand the GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS casestudy better are - – geopolitical disruptions, cloud computing is disrupting traditional business models, customer relationship management is fast transforming because of increasing concerns over data privacy, increasing energy prices, there is backlash against globalization, increasing government debt because of Covid-19 spendings, challanges to central banks by blockchain based private currencies,
there is increasing trade war between United States & China, increasing commodity prices, etc
Introduction to SWOT Analysis of GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS
SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University , we believe that protagonist in GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS case study can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the Imd449 Imd448, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which Imd449 Imd448 operates in.
According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.
SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix
SWOT analysis of GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS can be done for the following purposes –
1. Strategic planning using facts provided in GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS case study
2. Improving business portfolio management of Imd449 Imd448
3. Assessing feasibility of the new initiative in Leadership & Managing People field.
4. Making a Leadership & Managing People topic specific business decision
5. Set goals for the organization
6. Organizational restructuring of Imd449 Imd448
Strengths GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The strengths of Imd449 Imd448 in GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS Harvard Business Review case study are -
Cross disciplinary teams
– Horizontal connected teams at the Imd449 Imd448 are driving operational speed, building greater agility, and keeping the organization nimble to compete with new competitors. It helps are organization to ideate new ideas, and execute them swiftly in the marketplace.
Effective Research and Development (R&D)
– Imd449 Imd448 has innovation driven culture where significant part of the revenues are spent on the research and development activities. This has resulted in, as mentioned in case study GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS - staying ahead in the industry in terms of – new product launches, superior customer experience, highly competitive pricing strategies, and great returns to the shareholders.
Sustainable margins compare to other players in Leadership & Managing People industry
– GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS firm has clearly differentiated products in the market place. This has enabled Imd449 Imd448 to fetch slight price premium compare to the competitors in the Leadership & Managing People industry. The sustainable margins have also helped Imd449 Imd448 to invest into research and development (R&D) and innovation.
Low bargaining power of suppliers
– Suppliers of Imd449 Imd448 in the sector have low bargaining power. GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS has further diversified its suppliers portfolio by building a robust supply chain across various countries. This helps Imd449 Imd448 to manage not only supply disruptions but also source products at highly competitive prices.
High brand equity
– Imd449 Imd448 has strong brand awareness and brand recognition among both - the exiting customers and potential new customers. Strong brand equity has enabled Imd449 Imd448 to keep acquiring new customers and building profitable relationship with both the new and loyal customers.
Strong track record of project management
– Imd449 Imd448 is known for sticking to its project targets. This enables the firm to manage – time, project costs, and have sustainable margins on the projects.
Superior customer experience
– The customer experience strategy of Imd449 Imd448 in the segment is based on four key concepts – personalization, simplification of complex needs, prompt response, and continuous engagement.
Diverse revenue streams
– Imd449 Imd448 is present in almost all the verticals within the industry. This has provided firm in GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS case study a diverse revenue stream that has helped it to survive disruptions such as global pandemic in Covid-19, financial disruption of 2008, and supply chain disruption of 2021.
Ability to recruit top talent
– Imd449 Imd448 is one of the leading recruiters in the industry. Managers in the GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS are in a position to attract the best talent available. The firm has a robust talent identification program that helps in identifying the brightest.
Ability to lead change in Leadership & Managing People field
– Imd449 Imd448 is one of the leading players in its industry. Over the years it has not only transformed the business landscape in its segment but also across the whole industry. The ability to lead change has enabled Imd449 Imd448 in – penetrating new markets, reaching out to new customers, and providing different value propositions to different customers in the international markets.
Analytics focus
– Imd449 Imd448 is putting a lot of focus on utilizing the power of analytics in business decision making. This has put it among the leading players in the industry. The technology infrastructure suggested by Michael Yaziji, Anna Lindblom can also help it to harness the power of analytics for – marketing optimization, demand forecasting, customer relationship management, inventory management, information sharing across the value chain etc.
Successful track record of launching new products
– Imd449 Imd448 has launched numerous new products in last few years, keeping in mind evolving customer preferences and competitive pressures. Imd449 Imd448 has effective processes in place that helps in exploring new product needs, doing quick pilot testing, and then launching the products quickly using its extensive distribution network.
Weaknesses GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The weaknesses of GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS are -
Products dominated business model
– Even though Imd449 Imd448 has some of the most successful products in the industry, this business model has made each new product launch extremely critical for continuous financial growth of the organization. firm in the HBR case study - GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS should strive to include more intangible value offerings along with its core products and services.
High dependence on existing supply chain
– The disruption in the global supply chains because of the Covid-19 pandemic and blockage of the Suez Canal illustrated the fragile nature of Imd449 Imd448 supply chain. Even after few cautionary changes mentioned in the HBR case study - GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS, it is still heavily dependent upon the existing supply chain. The existing supply chain though brings in cost efficiencies but it has left Imd449 Imd448 vulnerable to further global disruptions in South East Asia.
No frontier risks strategy
– After analyzing the HBR case study GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS, it seems that company is thinking about the frontier risks that can impact Leadership & Managing People strategy. But it has very little resources allocation to manage the risks emerging from events such as natural disasters, climate change, melting of permafrost, tacking the rise of artificial intelligence, opportunities and threats emerging from commercialization of space etc.
Interest costs
– Compare to the competition, Imd449 Imd448 has borrowed money from the capital market at higher rates. It needs to restructure the interest payment and costs so that it can compete better and improve profitability.
High cash cycle compare to competitors
Imd449 Imd448 has a high cash cycle compare to other players in the industry. It needs to shorten the cash cycle by 12% to be more competitive in the marketplace, reduce inventory costs, and be more profitable.
Ability to respond to the competition
– As the decision making is very deliberative, highlighted in the case study GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS, in the dynamic environment Imd449 Imd448 has struggled to respond to the nimble upstart competition. Imd449 Imd448 has reasonably good record with similar level competitors but it has struggled with new entrants taking away niches of its business.
Compensation and incentives
– The revenue per employee as mentioned in the HBR case study GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS, is just above the industry average. Imd449 Imd448 needs to redesign the compensation structure and incentives to increase the revenue per employees. Some of the steps that it can take are – hiring more specialists on project basis, etc.
Lack of clear differentiation of Imd449 Imd448 products
– To increase the profitability and margins on the products, Imd449 Imd448 needs to provide more differentiated products than what it is currently offering in the marketplace.
Slow decision making process
– As mentioned earlier in the report, Imd449 Imd448 has a very deliberative decision making approach. This approach has resulted in prudent decisions, but it has also resulted in missing opportunities in the industry over the last five years. Imd449 Imd448 even though has strong showing on digital transformation primary two stages, it has struggled to capitalize the power of digital transformation in marketing efforts and new venture efforts.
High bargaining power of channel partners
– Because of the regulatory requirements, Michael Yaziji, Anna Lindblom suggests that, Imd449 Imd448 is facing high bargaining power of the channel partners. So far it has not able to streamline the operations to reduce the bargaining power of the value chain partners in the industry.
Workers concerns about automation
– As automation is fast increasing in the segment, Imd449 Imd448 needs to come up with a strategy to reduce the workers concern regarding automation. Without a clear strategy, it could lead to disruption and uncertainty within the organization.
Opportunities GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The opportunities highlighted in the Harvard Business Review case study GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS are -
Increase in government spending
– As the United States and other governments are increasing social spending and infrastructure spending to build economies post Covid-19, Imd449 Imd448 can use these opportunities to build new business models that can help the communities that Imd449 Imd448 operates in. Secondly it can use opportunities from government spending in Leadership & Managing People sector.
Reconfiguring business model
– The expansion of digital payment system, the bringing down of international transactions costs using Bitcoin and other blockchain based currencies, etc can help Imd449 Imd448 to reconfigure its entire business model. For example it can used blockchain based technologies to reduce piracy of its products in the big markets such as China. Secondly it can use the popularity of e-commerce in various developing markets to build a Direct to Customer business model rather than the current Channel Heavy distribution network.
Lowering marketing communication costs
– 5G expansion will open new opportunities for Imd449 Imd448 in the field of marketing communication. It will bring down the cost of doing business, provide technology platform to build new products in the Leadership & Managing People segment, and it will provide faster access to the consumers.
Loyalty marketing
– Imd449 Imd448 has focused on building a highly responsive customer relationship management platform. This platform is built on in-house data and driven by analytics and artificial intelligence. The customer analytics can help the organization to fine tune its loyalty marketing efforts, increase the wallet share of the organization, reduce wastage on mainstream advertising spending, build better pricing strategies using personalization, etc.
Changes in consumer behavior post Covid-19
– Consumer behavior has changed in the Leadership & Managing People industry because of Covid-19 restrictions. Some of this behavior will stay once things get back to normal. Imd449 Imd448 can take advantage of these changes in consumer behavior to build a far more efficient business model. For example consumer regular ordering of products can reduce both last mile delivery costs and market penetration costs. Imd449 Imd448 can further use this consumer data to build better customer loyalty, provide better products and service collection, and improve the value proposition in inflationary times.
Remote work and new talent hiring opportunities
– The widespread usage of remote working technologies during Covid-19 has opened opportunities for Imd449 Imd448 to expand its talent hiring zone. According to McKinsey Global Institute, 20% of the high end workforce in fields such as finance, information technology, can continously work from remote local post Covid-19. This presents a really great opportunity for Imd449 Imd448 to hire the very best people irrespective of their geographical location.
Leveraging digital technologies
– Imd449 Imd448 can leverage digital technologies such as artificial intelligence and machine learning to automate the production process, customer analytics to get better insights into consumer behavior, realtime digital dashboards to get better sales tracking, logistics and transportation, product tracking, etc.
Manufacturing automation
– Imd449 Imd448 can use the latest technology developments to improve its manufacturing and designing process in Leadership & Managing People segment. It can use CAD and 3D printing to build a quick prototype and pilot testing products. It can leverage automation using machine learning and artificial intelligence to do faster production at lowers costs, and it can leverage the growth in satellite and tracking technologies to improve inventory management, transportation, and shipping.
Finding new ways to collaborate
– Covid-19 has not only transformed business models of companies in Leadership & Managing People industry, but it has also influenced the consumer preferences. Imd449 Imd448 can tie-up with other value chain partners to explore new opportunities regarding meeting customer demands and building a rewarding and engaging relationship.
Redefining models of collaboration and team work
– As explained in the weaknesses section, Imd449 Imd448 is facing challenges because of the dominance of functional experts in the organization. GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS case study suggests that firm can utilize new technology to build more coordinated teams and streamline operations and communications using tools such as CAD, Zoom, etc.
Use of Bitcoin and other crypto currencies for transactions
– The popularity of Bitcoin and other crypto currencies as asset class and medium of transaction has opened new opportunities for Imd449 Imd448 in the consumer business. Now Imd449 Imd448 can target international markets with far fewer capital restrictions requirements than the existing system.
Better consumer reach
– The expansion of the 5G network will help Imd449 Imd448 to increase its market reach. Imd449 Imd448 will be able to reach out to new customers. Secondly 5G will also provide technology framework to build new tools and products that can help more immersive consumer experience and faster consumer journey.
Using analytics as competitive advantage
– Imd449 Imd448 has spent a significant amount of money and effort to integrate analytics and machine learning into its operations in the sector. This continuous investment in analytics has enabled, as illustrated in the Harvard case study GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS - to build a competitive advantage using analytics. The analytics driven competitive advantage can help Imd449 Imd448 to build faster Go To Market strategies, better consumer insights, developing relevant product features, and building a highly efficient supply chain.
Threats GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The threats mentioned in the HBR case study GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS are -
Environmental challenges
– Imd449 Imd448 needs to have a robust strategy against the disruptions arising from climate change and energy requirements. EU has identified it as key priority area and spending 30% of its 880 billion Euros European post Covid-19 recovery funds on green technology. Imd449 Imd448 can take advantage of this fund but it will also bring new competitors in the Leadership & Managing People industry.
Shortening product life cycle
– it is one of the major threat that Imd449 Imd448 is facing in Leadership & Managing People sector. It can lead to higher research and development costs, higher marketing expenses, lower customer loyalty, etc.
High dependence on third party suppliers
– Imd449 Imd448 high dependence on third party suppliers can disrupt its processes and delivery mechanism. For example -the current troubles of car makers because of chip shortage is because the chip companies started producing chips for electronic companies rather than car manufacturers.
Easy access to finance
– Easy access to finance in Leadership & Managing People field will also reduce the barriers to entry in the industry, thus putting downward pressure on the prices because of increasing competition. Imd449 Imd448 can utilize it by borrowing at lower rates and invest it into research and development, capital expenditure to fortify its core competitive advantage.
Stagnating economy with rate increase
– Imd449 Imd448 can face lack of demand in the market place because of Fed actions to reduce inflation. This can lead to sluggish growth in the economy, lower demands, lower investments, higher borrowing costs, and consolidation in the field.
Capital market disruption
– During the Covid-19, Dow Jones has touched record high. The valuations of a number of companies are way beyond their existing business model potential. This can lead to capital market correction which can put a number of suppliers, collaborators, value chain partners in great financial difficulty. It will directly impact the business of Imd449 Imd448.
Learning curve for new practices
– As the technology based on artificial intelligence and machine learning platform is getting complex, as highlighted in case study GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS, Imd449 Imd448 may face longer learning curve for training and development of existing employees. This can open space for more nimble competitors in the field of Leadership & Managing People .
Increasing wage structure of Imd449 Imd448
– Post Covid-19 there is a sharp increase in the wages especially in the jobs that require interaction with people. The increasing wages can put downward pressure on the margins of Imd449 Imd448.
Technology acceleration in Forth Industrial Revolution
– Imd449 Imd448 has witnessed rapid integration of technology during Covid-19 in the Leadership & Managing People industry. As one of the leading players in the industry, Imd449 Imd448 needs to keep up with the evolution of technology in the Leadership & Managing People sector. According to Mckinsey study top managers believe that the adoption of technology in operations, communications is 20-25 times faster than what they planned in the beginning of 2019.
Instability in the European markets
– European Union markets are facing three big challenges post Covid – expanded balance sheets, Brexit related business disruption, and aggressive Russia looking to distract the existing security mechanism. Imd449 Imd448 will face different problems in different parts of Europe. For example it will face inflationary pressures in UK, France, and Germany, balance sheet expansion and demand challenges in Southern European countries, and geopolitical instability in the Eastern Europe.
Technology disruption because of hacks, piracy etc
– The colonial pipeline illustrated, how vulnerable modern organization are to international hackers, miscreants, and disruptors. The cyber security interruption, data leaks, etc can seriously jeopardize the future growth of the organization.
Increasing international competition and downward pressure on margins
– Apart from technology driven competitive advantage dilution, Imd449 Imd448 can face downward pressure on margins from increasing competition from international players. The international players have stable revenue in their home market and can use those resources to penetrate prominent markets illustrated in HBR case study GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS .
Backlash against dominant players
– US Congress and other legislative arms of the government are getting tough on big business especially technology companies. The digital arm of Imd449 Imd448 business can come under increasing regulations regarding data privacy, data security, etc.
Weighted SWOT Analysis of GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS Template, Example
Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers in the HBR case study GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants.
We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –
First stage for doing weighted SWOT analysis of the case study GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.
Second stage for conducting weighted SWOT analysis of the Harvard case study GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.
Third stage of constructing weighted SWOT analysis of GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS is to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that Imd449 Imd448 needs to make to build a sustainable competitive advantage.